Hepatitis Forums

Hepatitis C Main Forums => Hepatitis C and HIV Coinfection => Topic started by: iana5252 on March 07, 2012, 12:31:32 pm

Title: Latest on HIV/HCV coinfection treatment
Post by: iana5252 on March 07, 2012, 12:31:32 pm

Hep editor Tim Horn is in Seattle this week covering the 19th Conference on Retroviruses and Opportunistic Infections (CROI). He reports there will be several updates on treatment options for HIV/HCV coinfection. Follow the latest here... http://ow.ly/9vN2l

First up:
Incivek, Victrelis Studies Hint at Superior Cure Rates in HIV/HCV Coinfection
http://ow.ly/9vN9W

Title: Re: Latest on HIV/HCV coinfection treatment
Post by: fullof? on March 15, 2012, 10:12:12 am

Thanks for the posting. So is it safe to take the new drugs if you are also fighthing hiv?

Title: Re: Latest on HIV/HCV coinfection treatment
Post by: iana5252 on April 05, 2012, 09:36:07 am

The latest on HIV and Hep C treatment recommendations.

Important preliminary recommendations involving the use of hepatitis C protease inhibitors among people living with HIV are provided by U.S. Department of Health and Human Services panelists in the March 27 update to the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Though both Incivek (telaprevir) and Victrelis (boceprevir) are listed as options, the panelists draw upon drug-drug interaction data to conclude that Incivek should be used instead of Victrelis when ARV regimens that include Norvir (ritonavir)–boosted Reyataz (atazanavir) or efavirenz (found in Sustiva and Atripla) are being used to treat HIV.

Complete story...
http://www.hepmag.com/articles/hiv_hepatitis_guidelines_2501_22186.shtml